256 related articles for article (PubMed ID: 18675590)
1. Will new antischistosomal drugs finally emerge?
Cioli D; Valle C; Angelucci F; Miele AE
Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
[TBL] [Abstract][Full Text] [Related]
2. Schistosomiasis control: praziquantel forever?
Cioli D; Pica-Mattoccia L; Basso A; Guidi A
Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
[TBL] [Abstract][Full Text] [Related]
3. Schistosomiasis: challenges for control, treatment and drug resistance.
Fenwick A; Webster JP
Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
[TBL] [Abstract][Full Text] [Related]
4.
Oyinloye BE; Shamaki DE; Agbebi EA; Onikanni SA; Ubah CS; Aruleba RT; Dao TNP; Owolabi OV; Idowu OT; Mathenjwa-Goqo MS; Esan DT; Ajiboye BO; Omotuyi OI
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731401
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular bases of antischistosomal therapy.
Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
[TBL] [Abstract][Full Text] [Related]
6. Potent Inhibitors of Thioredoxin Glutathione Reductase: Grail of Anti-Schistosome Drug within Reach?
Tripathi T; Chetri PB
ACS Infect Dis; 2020 May; 6(5):893-895. PubMed ID: 32159329
[TBL] [Abstract][Full Text] [Related]
7. Praziquantel.
Cioli D; Pica-Mattoccia L
Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.
Kuntz AN; Davioud-Charvet E; Sayed AA; Califf LL; Dessolin J; Arnér ES; Williams DL
PLoS Med; 2007 Jun; 4(6):e206. PubMed ID: 17579510
[TBL] [Abstract][Full Text] [Related]
9. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
Rai G; Sayed AA; Lea WA; Luecke HF; Chakrapani H; Prast-Nielsen S; Jadhav A; Leister W; Shen M; Inglese J; Austin CP; Keefer L; Arnér ES; Simeonov A; Maloney DJ; Williams DL; Thomas CJ
J Med Chem; 2009 Oct; 52(20):6474-83. PubMed ID: 19761212
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.
Lyu H; Petukhov PA; Banta PR; Jadhav A; Lea WA; Cheng Q; Arnér ESJ; Simeonov A; Thatcher GRJ; Angelucci F; Williams DL
ACS Infect Dis; 2020 Mar; 6(3):393-405. PubMed ID: 31939288
[TBL] [Abstract][Full Text] [Related]
11. [Toxicity of several drugs against Schistosoma japonicum adult worms in vitro].
Song LJ; Yu CX; Zeng HH; Qian CY; Yin XR; Wang J; Hua WQ; Xu YL; Zhang W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Feb; 23(1):54-60. PubMed ID: 22164376
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
13. Toward organometallic antischistosomal drug candidates.
Hess J; Keiser J; Gasser G
Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
[TBL] [Abstract][Full Text] [Related]
14. New drugs for an ancient parasite.
Loukas A; Bethony JM
Nat Med; 2008 Apr; 14(4):365-7. PubMed ID: 18391931
[No Abstract] [Full Text] [Related]
15. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
[TBL] [Abstract][Full Text] [Related]
16. Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target.
Eweas AF; Allam G
Mol Biochem Parasitol; 2018 Oct; 225():94-102. PubMed ID: 30291946
[TBL] [Abstract][Full Text] [Related]
17. Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum.
Song LJ; Luo H; Fan WH; Wang GP; Yin XR; Shen S; Wang J; Jin Y; Zhang W; Gao H; Liu Q; Wang WL; Feng B; Yu CX
Parasit Vectors; 2016 Jan; 9():26. PubMed ID: 26791563
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum.
Song L; Li J; Xie S; Qian C; Wang J; Zhang W; Yin X; Hua Z; Yu C
PLoS One; 2012; 7(2):e31456. PubMed ID: 22384025
[TBL] [Abstract][Full Text] [Related]
19. Identification of oxadiazoles as new drug leads for the control of schistosomiasis.
Sayed AA; Simeonov A; Thomas CJ; Inglese J; Austin CP; Williams DL
Nat Med; 2008 Apr; 14(4):407-12. PubMed ID: 18345010
[TBL] [Abstract][Full Text] [Related]
20. [Advances in research on antischistosomal drugs].
Qiu SJ; Xia CM
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
